Countable PCR delivers single-molecule precision for Europe's most demanding quantification challenges — from cell and gene therapy manufacturing to biomarker validation, diagnostics, commercial ...
Leading life sciences investors ARCH Venture Partners, F-Prime Capital, and Primer Ventures fuel company's expansion into cell and gene therapy, oncology, and molecular diagnostics Countable Labs, the ...
Unless you spend your free time watching hours of C-SPAN, the odds are you aren’t too keenly aware of the inner workings of Congress and instead rely on hysterical headlines from MSNBC, Fox News and ...
Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures biology, announced a co-marketing agreement with Promega, a leader in ...
Beth Skwarecki is Lifehacker’s Senior Health Editor, and holds certifications as a personal trainer and weightlifting coach. She has been writing about health for over 10 years. February 21, 2017 Add ...
Enterprise engagement company Countable raised $12 million in Series A funding so that brands can more easily engage with customers, even in a way that shows a brand’s values and stance on issues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results